Xenon Pharmaceuticals Inc (XENE) stock news · rev $7.5M
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
This XENE news page leads with what Xenon Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for XENE yet. We will not pad this page with generic market recap.
Latest reported XENE revenue for 2025-12-31 was $7.5M. Net income was -$345.9M. XENE currently screens at market cap $2.55B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the XENE stock page; for the tape open the quote page.
XENE stock news FAQ
What are XENE's latest revenue and net income?
Latest cached Xenon Pharmaceuticals Inc (XENE) revenue for Dec 31, 2025 was $7.5M. Net income was -$345.9M. Statements: https://lician.com/financials/xene
What is XENE's market cap?
Xenon Pharmaceuticals Inc (XENE) market cap is $2.55B on the latest cached fundamentals snapshot.
What kind of company is XENE?
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Where is XENE stock news listed?
Cached stock news for Xenon Pharmaceuticals Inc (XENE) is listed at https://lician.com/news/xene. Filings: https://lician.com/sec/xene
Not investment advice.